GLP-1s May Reduce Cancer Progression

[upbeat music] Are you really more of an optimist about these drugs than I, than I realized? Perhaps I've mislabeled you as a skeptic.

What I think that we're qualified to comment on is the business side of it, which I find fascinating, and then also the potential that they have for a lot of different indications and, and possibilities.

And yes, I do find it very, uh, interesting and exciting, but I d- I don't [chuckles] wanna get ahead of the, uh, the trials.

I think the, the thing that's going to be tricky is these are expensive drugs, even at the current reduced cost, and the scale of the utilization is still growing, to your point.

So it's gonna be a challenge unless people can see a lo- a, a relatively short-term ROI.

But I, I think, I think, w- you know, where you can get dramatic and sustained weight loss, I think you're gonna see that, Dave.

I mean, I'm, I'm, I'm a, I'm a, I'm a positive on this one.

I, I do think what the, the, the, and the thing that's most exciting is you're going to see, because of the success, a lot of research and money go towards seeing whether this similar formulation can be tuned to solve other problems.

John, let's, let's stick for another one more minute on the weight loss side of it.

And we hear a lot about the GLP-1 rebound rate.

Uh, there was a study that showed about 60% of weight loss that was gained during treatments was regained within a year.

[upbeat music]